• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Case of Persistent Intra-Abdominal Infection Despite Bacteriophage Therapy.一例尽管接受噬菌体治疗但仍持续存在腹腔内感染的病例。
Phage (New Rochelle). 2024 Sep 16;5(3):120-125. doi: 10.1089/phage.2023.0034. eCollection 2024 Sep.
2
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD004197. doi: 10.1002/14651858.CD004197.pub5.
3
Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.囊性纤维化患者嗜麦芽窄食单胞菌的抗生素治疗
Cochrane Database Syst Rev. 2016 Jul 14;7(7):CD009249. doi: 10.1002/14651858.CD009249.pub4.
4
Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.囊性纤维化患者嗜麦芽窄食单胞菌的抗生素治疗
Cochrane Database Syst Rev. 2012 May 16(5):CD009249. doi: 10.1002/14651858.CD009249.pub2.
5
Ceftazidime retains efficacy against strains of for which traditional testing predicts resistance.头孢他啶对传统检测预测为耐药的菌株仍保持疗效。
mSphere. 2025 Jun 25;10(6):e0084024. doi: 10.1128/msphere.00840-24. Epub 2025 May 22.
6
Carbon dioxide detection for diagnosis of inadvertent respiratory tract placement of enterogastric tubes in children.用于诊断儿童肠胃管意外置入呼吸道的二氧化碳检测
Cochrane Database Syst Rev. 2025 Feb 19;2(2):CD011196. doi: 10.1002/14651858.CD011196.pub2.
7
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
8
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
9
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
10
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.与标准护理相比,自动监测用于危重症患者脓毒症的早期检测
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012404. doi: 10.1002/14651858.CD012404.pub2.

本文引用的文献

1
Class-Driven Synergy and Antagonism between a Pseudomonas Phage and Antibiotics.基于类别的噬菌体与抗生素协同与拮抗作用
Infect Immun. 2023 Aug 16;91(8):e0006523. doi: 10.1128/iai.00065-23. Epub 2023 Jul 5.
2
A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes.一项 12 例扩展准入定制噬菌体治疗的回顾性观察性研究:生产、特征和临床结果。
Clin Infect Dis. 2023 Oct 13;77(8):1079-1091. doi: 10.1093/cid/ciad335.
3
Antibiotics targeting bacterial protein synthesis reduce the lytic activity of bacteriophages.针对细菌蛋白质合成的抗生素会降低噬菌体的裂解活性。
Virus Res. 2022 Nov;321:198909. doi: 10.1016/j.virusres.2022.198909. Epub 2022 Aug 31.
4
Clinical challenges treating infections: an update.感染治疗中的临床挑战:最新进展
JAC Antimicrob Resist. 2022 May 5;4(3):dlac040. doi: 10.1093/jacamr/dlac040. eCollection 2022 Jun.
5
Considerations for the Use of Phage Therapy in Clinical Practice.考虑在临床实践中使用噬菌体疗法。
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0207121. doi: 10.1128/AAC.02071-21. Epub 2022 Jan 18.
6
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies.噬菌体治疗的安全性和毒性:动物和临床研究综述。
Viruses. 2021 Jun 29;13(7):1268. doi: 10.3390/v13071268.
7
The Potential of Phage Therapy against the Emerging Opportunistic Pathogen .噬菌体疗法对抗新兴机会性病原体的潜力
Viruses. 2021 Jun 3;13(6):1057. doi: 10.3390/v13061057.
8
Aminoglycosides Antagonize Bacteriophage Proliferation, Attenuating Phage Suppression of Bacterial Growth, Biofilm Formation, and Antibiotic Resistance.氨基糖苷类抗生素拮抗噬菌体增殖,减弱噬菌体对细菌生长、生物膜形成和抗生素耐药性的抑制作用。
Appl Environ Microbiol. 2021 Jul 13;87(15):e0046821. doi: 10.1128/AEM.00468-21.
9
Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States.从美国一家中心连续治疗多药耐药细菌感染的首例10例静脉注射噬菌体疗法中吸取的经验教训。
Open Forum Infect Dis. 2020 Aug 27;7(9):ofaa389. doi: 10.1093/ofid/ofaa389. eCollection 2020 Sep.
10
Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.噬菌体-抗生素协同作用是由独特的抗菌作用机制和化学计量比组合驱动的。
mBio. 2020 Aug 4;11(4):e01462-20. doi: 10.1128/mBio.01462-20.

一例尽管接受噬菌体治疗但仍持续存在腹腔内感染的病例。

A Case of Persistent Intra-Abdominal Infection Despite Bacteriophage Therapy.

作者信息

Cullen Grace D, Salazar Keiko Christine, Terwilliger Austen Lee, Aslam Saima, Clark Justin R, Maresso Anthony W, Bollyky Paul L, Aronson Jenny R

机构信息

The Department of Internal Medicine, Stanford University School of Medicine, Palo Alto, California, USA.

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Palo Alto, California, USA.

出版信息

Phage (New Rochelle). 2024 Sep 16;5(3):120-125. doi: 10.1089/phage.2023.0034. eCollection 2024 Sep.

DOI:10.1089/phage.2023.0034
PMID:39372359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11447384/
Abstract

Multidrug resistant infections are a challenge in the health care setting and a cause of patient morbidity and mortality. Bacteriophages (phages) are viruses that target and kill bacteria and have been used in patients to treat bacterial infections. We present a case of disseminated infection, with pulmonary, intra-abdominal and bloodstream involvement. The patient was treated with a combination of antibiotics and personalized phage therapy, administered daily for 12 days both intravenously as well as intra-abdominal drains. Phage therapy was well-tolerated, the patient cleared from their bloodstream and their intra-abdominal abscesses were stable or decreased in size. However, the intra-abdominal fluid cultures remained positive for . Unfortunately, the patient passed away 2 months after completion of phage therapy due to multiorgan failure. These data highlight the difficulty of treating critically ill patients and clearing complex, biofilm mediated infections, even with phages. More information is needed regarding the optimal treatment protocols for phage therapy in complex multifocal infections.

摘要

多重耐药感染是医疗环境中的一项挑战,也是患者发病和死亡的一个原因。噬菌体是靶向并杀死细菌的病毒,已用于患者治疗细菌感染。我们报告一例播散性感染病例,累及肺部、腹腔内和血液。该患者接受了抗生素和个性化噬菌体疗法的联合治疗,静脉内和腹腔引流管每日给药,持续12天。噬菌体疗法耐受性良好,患者血液中感染清除,腹腔内脓肿稳定或缩小。然而,腹腔积液培养物仍对……呈阳性。不幸的是,患者在噬菌体治疗完成2个月后因多器官衰竭去世。这些数据凸显了治疗重症患者以及清除复杂的、生物膜介导的感染的困难,即使使用噬菌体也是如此。对于复杂多灶性感染中噬菌体疗法的最佳治疗方案,还需要更多信息。